Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Galactose-based intravenous sonographic contrast agent: experimental studies

B B Goldberg1, J B Liu, P N Burns

  • 1Department of Radiology, Thomas Jefferson University Hospital, Philadelphia, Pennsylvania 19107.

Journal of Ultrasound in Medicine : Official Journal of the American Institute of Ultrasound in Medicine
|August 1, 1993
PubMed
Summary

A new galactose-based ultrasound contrast agent effectively enhances Doppler signals in various blood vessels, including small ones, after intravenous injection in animal studies. This agent shows potential for future clinical diagnostic applications.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Clinical impact of CEUS on non-characterizable observations and observations with intermediate probability of malignancy on CT/MRI in patients at risk for HCC.

Abdominal radiology (New York)·2024
Same author

Transrectal Subharmonic Ultrasound Imaging for Prostate Cancer Detection.

Urology·2020
Same author

Subharmonic aided pressure estimation for monitoring interstitial fluid pressure in tumours--in vitro and in vivo proof of concept.

Ultrasonics·2014
Same author

Electromechanical piezoresistive sensing in suspended graphene membranes.

Nano letters·2013
Same author

On the implementation of an automated acoustic output optimization algorithm for subharmonic aided pressure estimation.

Ultrasonics·2013
Same author

Guidelines and good clinical practice recommendations for contrast enhanced ultrasound (CEUS) in the liver--update 2012: a WFUMB-EFSUMB initiative in cooperation with representatives of AFSUMB, AIUM, ASUM, FLAUS and ICUS.

Ultraschall in der Medizin (Stuttgart, Germany : 1980)·2012

Area of Science:

  • Medical Imaging
  • Ultrasound Technology
  • Pharmacology

Background:

  • Ultrasound contrast agents improve diagnostic imaging.
  • Microbubble agents enhance Doppler signals.
  • Galactose-based agents offer unique properties.

Purpose of the Study:

  • To evaluate a galactose-based sonographic contrast agent.
  • To assess its ability to enhance Doppler signals in various vessels and tissues.
  • To determine its efficacy in animal models.

Main Methods:

  • Intravenous injection of a galactose-based microbubble contrast agent in dogs, rabbits, and woodchucks.
  • Assessment of Doppler signal enhancement in normal and tumor tissues, and blood vessels.
  • Evaluation of enhancement after bolus injection and continuous infusion.

Related Experiment Videos

Main Results:

  • Significant enhancement of color and spectral Doppler signals in diverse blood vessels, from large (aorta) to small (retinal, renal).
  • Demonstrated Doppler enhancement in naturally occurring woodchuck hepatomas.
  • Peak enhancement of ~10 dB after bolus injection; sustained enhancement of ~14 dB with infusion.
  • Agent provided enhancement for over 3 minutes post-bolus and over 5 minutes with infusion.

Conclusions:

  • The galactose-based agent effectively enhances Doppler signals in various blood vessels, including small ones.
  • It shows potential for improving ultrasound diagnostics, particularly in vascular imaging.
  • Further clinical applications are suggested based on promising animal study results.